Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, et al.
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students
|
January 17, 2009
An invitation to the medical students of the world to join the global coalition to improve care for children and adults with congenital heart disease across the world
Pierre-Luc Bernier, Noritaka Otal, Christo I Tchervenkov, et al.
Frontiers in Oncology
|
February 15, 2024
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults
Nicola Fenwick, Rebekah Weston, Keith Wheatley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2020
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
Keith Holmes, Ulrike Pötschger, Andrew D J Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
Juliet C Gray, Rebekah Weston, Cormac Owens, et al.
Cancer Discovery
|
December 18, 2024
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
Sally L George, Claire Lynn, Reda Stankunaite, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, et al.
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students
|
January 17, 2009
An invitation to the medical students of the world to join the global coalition to improve care for children and adults with congenital heart disease across the world
Pierre-Luc Bernier, Noritaka Otal, Christo I Tchervenkov, et al.
Frontiers in Oncology
|
February 15, 2024
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults
Nicola Fenwick, Rebekah Weston, Keith Wheatley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2020
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
Keith Holmes, Ulrike Pötschger, Andrew D J Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
Juliet C Gray, Rebekah Weston, Cormac Owens, et al.
Cancer Discovery
|
December 18, 2024
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
Sally L George, Claire Lynn, Reda Stankunaite, et al.
Page
of 8